Holen Sie sich die Stockscreener-App
20.72
2.86%
-0.61
Schlusskurs vom Vortag:
$21.33
Offen:
$21.54
24-Stunden-Volumen:
178.43K
Relative Volume:
0.70
Marktkapitalisierung:
$532.27M
Einnahmen:
-
Nettoeinkommen (Verlust:
$11.77M
KGV:
35.82
EPS:
0.5785
Netto-Cashflow:
$-19.23M
1W Leistung:
-4.78%
1M Leistung:
+27.27%
6M Leistung:
+45.10%
1J Leistung:
+42.50%
1-Tages-Spanne:
$19.75
$21.67
1-Wochen-Bereich:
$19.75
$22.93
52-Wochen-Spanne:
$11.56
$29.79
Tourmaline Bio Inc Stock (TRML) Company Profile
Firmenname
Tourmaline Bio Inc
Sektor
Branche
Telefon
646-481-9832
Adresse
27 WEST 24TH STREET, NEW YORK
Vergleichen Sie TRML mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
TRML
Tourmaline Bio Inc
|
20.72 | 563.61M | 0 | 11.77M | -19.23M | 0.5785 |
|
VRTX
Vertex Pharmaceuticals Inc
|
366.54 | 98.88B | 11.42B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
563.00 | 58.84B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
438.93 | 56.12B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
661.83 | 41.20B | 3.05B | 1.28B | -614.78M | 19.58 |
|
ONC
Beone Medicines Ltd Adr
|
288.18 | 35.49B | 3.81B | -644.79M | -669.77M | -6.24 |
Tourmaline Bio Inc Stock (TRML) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-23 | Eingeleitet | Chardan Capital Markets | Buy |
| 2025-03-06 | Eingeleitet | Wedbush | Outperform |
| 2024-12-06 | Eingeleitet | BMO Capital Markets | Outperform |
| 2024-11-11 | Bestätigt | H.C. Wainwright | Buy |
| 2023-12-15 | Eingeleitet | Jefferies | Buy |
| 2023-12-04 | Fortgesetzt | H.C. Wainwright | Buy |
| 2023-11-17 | Eingeleitet | Truist | Buy |
| 2023-10-31 | Eingeleitet | Guggenheim | Buy |
| 2023-10-25 | Eingeleitet | Piper Sandler | Overweight |
| 2022-10-20 | Eingeleitet | H.C. Wainwright | Buy |
| 2022-07-05 | Herabstufung | Morgan Stanley | Overweight → Equal-Weight |
Alle ansehen
Tourmaline Bio Inc Aktie (TRML) Neueste Nachrichten
Is Tourmaline Bio Inc. stock ready for a breakoutLow-Risk Reversal Pattern Analysis Tracker - Newser
Why Tourmaline Bio Inc. stock attracts strong analyst attentionSmart Entry Signals for Active Traders - Newser
New Product Launches: Will They Boost Tourmaline Bio Inc. Stock in 2025Buy and Hold Strategy for Capital Safety - Newser
Will Tourmaline Bio Inc. continue its uptrendOversold Stock Bounce Playbook Generator - Newser
How Tourmaline Bio Inc. stock performs during market volatilityReliable Setup Screener with Low Risk - Newser
Reversal indicators forming on Tourmaline Bio Inc. stockPrice Action Trading with Volume Confirmation - Newser
What makes Tourmaline Bio Inc. stock price move sharplyEntry Zone Watchlist With Momentum Focus - Newser
How high can Tourmaline Bio Inc. stock goFree Earnings Play Trade Plan With Alerts - Newser
Published on: 2025-08-08 22:37:48 - Newser
How to track smart money flows in Tourmaline Bio Inc.Downside Risk Evaluation and Stock Analysis - Newser
Analyzing Tourmaline Bio Inc. with multi timeframe chartsQuarterly Investment Outlook and Key Summary - Newser
What to do if you’re stuck in Tourmaline Bio Inc.Neural Model for Stock Price Movement - Newser
Will Tourmaline Bio Inc. stock recover after recent dropTechnical Chart Summary for Momentum Stocks - Newser
Is Tourmaline Bio Inc. forming a reversal patternFree Market Momentum and Signal Alerts - Newser
Tourmaline Bio Inc. stock chart pattern explainedPredicted Market Direction Based on Momentum - Newser
Is Tourmaline Bio Inc. stock a good hedge against inflationTechnical Chart Summary for Momentum Stocks - Newser
Tourmaline Bio (TRML) Expected to Announce Earnings on Thursday - Defense World
Can momentum traders help lift Tourmaline Bio Inc.Free Safe Entry Stock Watch Suggestions - Newser
Is Tourmaline Bio Inc. stock entering bullish territoryFree Optimized Watchlist With Daily Adjustments - Newser
Tourmaline Bio (NASDAQ:TRML) Is In A Good Position To Deliver On Growth Plans - 富途牛牛
Tourmaline Bio Inc expected to post a loss of 94 cents a shareEarnings Preview - TradingView
Building trade automation scripts for Tourmaline Bio Inc.Weekly Price Target Forecast and Alerts - Newser
When is Tourmaline Bio Inc. stock expected to show significant growthPhenomenal capital gains - Jammu Links News
Tourmaline Bio Inc. Stock Analysis and ForecastDiscover stocks with strong growth potential - Jammu Links News
What is the dividend policy of Tourmaline Bio Inc. stockUnlock high-yield investment opportunities - Jammu Links News
Does Tourmaline Bio Inc. stock perform well during market downturnsConsistent high-yield stocks - Jammu Links News
What drives Tourmaline Bio Inc. stock priceFree Real-Time Stock Data - Jammu Links News
What analysts say about Tourmaline Bio Inc. stockDiscover stock picks with superior returns - Jammu Links News
What are Tourmaline Bio Inc. company’s key revenue driversBreakthrough stock performance - Jammu Links News
Should I hold or sell Tourmaline Bio Inc. stock in 2025Overwhelming profit margins - Jammu Links News
What institutional investors are buying Tourmaline Bio Inc. stockAchieve breakthrough profits with expert advice - Jammu Links News
Is Tourmaline Bio Inc. a good long term investmentInvest confidently with expert support - Jammu Links News
How strong is Tourmaline Bio Inc. company’s balance sheetAccess exclusive market insights for free - Jammu Links News
What are analysts’ price targets for Tourmaline Bio Inc. in the next 12 monthsUnlock powerful portfolio optimization tools - Jammu Links News
What are the latest earnings results for Tourmaline Bio Inc.Unlock powerful portfolio management tools - Jammu Links News
What catalysts could drive Tourmaline Bio Inc. stock higher in 2025Rapid profit acceleration - Jammu Links News
Finanzdaten der Tourmaline Bio Inc-Aktie (TRML)
Umsatz
Nettogewinn
Free Cashflow
ENV
Tourmaline Bio Inc-Aktie (TRML) Insiderhandel
| Insiderhandel | Beziehung | Datum | Transaktion | Kosten | #Aktien | Wert ($) | #Aktien Gesamt |
|---|---|---|---|---|---|---|---|
| Kulkarni Sandeep Chidambar | CEO |
Aug 16 '24 |
Buy |
13.79 |
5,221 |
71,998 |
5,221 |
0.24%
3.39%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):